1. Academic Validation
  2. Blockade of proteinase-activated receptor 4 inhibits neutrophil recruitment in experimental inflammation in mice

Blockade of proteinase-activated receptor 4 inhibits neutrophil recruitment in experimental inflammation in mice

  • Inflamm Res. 2014 Nov;63(11):935-41. doi: 10.1007/s00011-014-0767-8.
Lindisley F Gomides 1 Onésia C O Lima Natália A Matos Kátia M Freitas Janetti Nogueira Francischi Juliana Carvalho Tavares André Klein
Affiliations

Affiliation

  • 1 Departamento de Farmacologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627 Pampulha, 31270-901, Belo Horizonte, MG, Brazil.
Abstract

Objective and design: The activation of proteinase-activated receptors (PARs) has been implicated in the development of important hallmarks of inflammation, including in vivo leukocyte recruitment; however, its role in the regulation of leukocyte migration in response to inflammatory stimuli has not been elucidated until now. Here, we examined the effects of the PAR4 Antagonist YPGKF-NH 2 (tcY-NH2) on neutrophil recruitment in experimentally induced inflammation.

Methods: BALB/c mice were intrapleurally injected with tcY-NH2 (40 ng/kg) prior to intrapleural injection of carrageenan (Cg) or neutrophil chemoattractant CXCL8; the number of infiltrating neutrophils was evaluated after 4 h, and KC production was assessed at different times after Cg injection. Neutrophil adhesion and rolling cells were studied using a brain circulation preparation 4 h after the Cg or CXCL8 challenge in tcY-NH2-treated mice.

Results: PAR4 blockade inhibited CXCL8- and Cg-induced neutrophil migration into the pleural cavity of BALB/c mice and reduced neutrophil rolling and adherence. Surprisingly, PAR4 blockade increased the level of KC in response to carrageenan.

Conclusion: These results demonstrated that PAR4 blockade impairs neutrophil migration in vivo, suggesting that PAR4 plays an important role in the regulation of inflammation, at least in part because of its ability to inhibit the actions of the neutrophil chemoattractant CXCL8.

Figures
Products